BioGaia AB (publ) BioGaia AB (publ)

BioGaia AB (publ)

BIOG-B

Rangering i aksjer #7814
BioGaia AB (publ), a Swedish enterprise founded in 1990 and headquartered in... BioGaia AB (publ), a Swedish enterprise founded in 1990 and headquartered in Stockholm, is dedicated to the worldwide development, marketing, and distribution of probiotic products renowned for their scientifically proven health advantages. The company operates through three primary divisions. Its Pediatrics segment offers various items such as drops, oral rehydration solutions, and gut health tablets, in addition to supplying cultures for integration into infant formula. The Adult Health segment provides gut health tablets and oral health lozenges, alongside furnishing cultures to licensees for use in dairy products. A third segment, "Other," specializes in packaging solutions. BioGaia's extensive product portfolio targets a range of health issues, including infantile colic and digestive health in children, antibiotic-associated and acute diarrhea, gingivitis, periodontal disease, general well-being, Helicobacter pylori bacterial infections (linked to gastric ulcers), and concerns related to low bone density. All of its offerings are sold exclusively under the BioGaia brand.
Aksjekurs
$13.83
Markedsverdi
$1.36B
Endring (1 dag)
-0.56%
Endring (1 år)
22.91%
Land
SE
Handel BioGaia AB (publ) (BIOG-B)

Kategori

Healthcare
Antall utestående aksjer for BioGaia AB (publ) (BIOG-B)
Antall utestående aksjer per October 2026: 0
Ifølge BioGaia AB (publ) sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 0. Ved slutten av October 2026 hadde selskapet 0 utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for BioGaia AB (publ) (BIOG-B) fra 2026 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
Ikke nok data for de angitte datoene.
Utestående aksjer for lignende selskaper eller konkurrenter